High-tissue FRMD6 expression predicts better outcomes among colorectal cancer patients.

Arthur von KoskullJaana Hagstrom Caj Haglund Tuomas Kaprio Camilla Böckelman

Published in: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals (2024)

To our knowledge, this is the first study to show that a high FRMD6 expression is an independent marker for a better prognosis in CRC and could help determine the prognosis for CRC patients.

Keyphrases

poor prognosis
end stage renal disease
ejection fraction
newly diagnosed
healthcare
binding protein
prognostic factors
long non coding rna
patient reported outcomes